“Tirzepatide 30mg Vial” has been added to your cart. View cart
Retatrutide 40mg Pen
£150.00
⚠️ This is a research-only compound. Not approved for clinical or human use.
Shipping 14-28 Days
Description
Retatrutide is an investigational triple agonist compound that simultaneously targets GIP, GLP-1, and glucagon receptors. It is being explored in research for its potential in treating obesity and metabolic disorders. This compound is experimental and intended for research use only.
Reviews (0)
Be the first to review “Retatrutide 40mg Pen” Cancel reply
Reviews
There are no reviews yet.